| Title | Nature Reviews Cancer |
| Abbreviation | Nat. Rev. Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q1); Oncology (Q1) |
| h-index | 484 |
| Overall Rank/Ranking | 11 |
| SCImago Journal Rank (SJR) | 20.977 |
| Impact Score | 37.34 |
| Publisher | Nature Publishing Group |
| Country | United Kingdom |
| ISSN | 1474175X, 14741768 |
| Best Quartile | Q1 |
| Coverage History | 2001-2022 |
The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers carcinogenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient"s prognosis we need to appreciate which molecular changes affect tumour growth rate and invasiveness. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a "normal" cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research.
Nature Reviews Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Oncology (Q1). It is published by Nature Publishing Group. The overall rank of Nature Reviews Cancer is 11. According to SCImago Journal Rank (SJR), this journal is ranked 20.977. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 484. The best quartile for this journal is Q1.
The ISSN of Nature Reviews Cancer journal is 1474175X, 14741768. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nature Reviews Cancer is cited by a total of 10528 articles during the last 3 years (Preceding 2022).
The impact score (IS) 2022 of Nature Reviews Cancer is 37.34, which is computed in 2023 as per its definition. Nature Reviews Cancer IS is increased by a factor of 9.88 and approximate percentage change is 35.98% when compared to preceding year 2021, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2022 of Nature Reviews Cancer is 37.34. If the same upward trend persists, impact score may rise in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 37.34 |
| 2021 | 27.46 |
| 2020 | 18.41 |
| 2019 | 22.11 |
| 2018 | 25.38 |
| 2017 | 21.47 |
| 2016 | 16.71 |
| 2015 | 15.64 |
| 2014 | 16.71 |
Nature Reviews Cancer has an h-index of 484. It means 484 articles of this journal have more than 484 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Nature Reviews Cancer is 1474175X, 14741768. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Nature Reviews Cancer is 11. According to SCImago Journal Rank (SJR), this journal is ranked 20.977. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 20.977 |
| 2021 | 16.955 |
| 2020 | 19.575 |
| 2019 | 21.287 |
| 2018 | 28.061 |
| 2017 | 23.530 |
| 2016 | 22.315 |
| 2015 | 25.056 |
| 2014 | 24.923 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 11 |
| 2021 | 21 |
| 2020 | 16 |
| 2019 | 10 |
| 2018 | 7 |
| 2017 | 11 |
| 2016 | 10 |
| 2015 | 9 |
| 2014 | 9 |
Nature Reviews Cancer is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Nature Reviews Cancer is Nat. Rev. Cancer. This abbreviation ('Nat. Rev. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the Nature Reviews Cancer is 37.34. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 37.34 (2022) and 15.64 (2015), respectively, in the last 9 years. Moreover, its average IS is 22.36 in the previous 9 years.
The Nature Reviews Cancer has an SJR (SCImago Journal Rank) of 20.977, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 28.061 in 2018 and the lowest being 16.955 in 2021. Furthermore, the average SJR of the Nature Reviews Cancer over the previous 9-year period stands at 22.36.
The latest h-index of the Nature Reviews Cancer is 484.
The Nature Reviews Cancer is published by the Nature Publishing Group, with its country of publication being the United Kingdom.
The Nature Reviews Cancer is currently ranked 11 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 7 in 2018 and its lowest position of 21 in 2021.
The standard ISO4 abbreviation for the Nature Reviews Cancer is Nat. Rev. Cancer.
Nature Reviews Cancer is classified as a journal that the Nature Publishing Group publishes.
The Nature Reviews Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Nature Reviews Cancer is assigned the following International Standard Serial Numbers (ISSN): 1474175X, 14741768.
The best quartile for the Nature Reviews Cancer is Q1 (2022).
The Nature Reviews Cancer coverage history can be summarized as follows: 2001-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Journal of Business Finance and Accounting | journal | 3221 | Wiley-Blackwell Publishing Ltd | 84 | 3.68 |
| Child and Family Social Work | journal | 8628 | Wiley-Blackwell Publishing Ltd | 67 | 2.20 |
| Howard Journal of Communications | journal | 9564 | Taylor and Francis Ltd. | 36 | 1.66 |
| European Surgery - Acta Chirurgica Austriaca | journal | 16873 | Springer Medizin | 23 | 0.58 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Exploration Geophysics | journal | 16383 | Taylor and Francis Ltd. | 48 | 1.17 |
| International Journal of Pest Management | journal | 13393 | Taylor and Francis Ltd. | 50 | 1.50 |
| Psycho-Oncologie | journal | 24009 | Springer Paris | 11 | 0.13 |
| Journal of Medical Toxicology | journal | 8639 | Springer New York | 55 | 2.01 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 37.34 |
| 2021 | 27.46 |
| 2020 | 18.41 |
| 2019 | 22.11 |
| 2018 | 25.38 |
| 2017 | 21.47 |
| 2016 | 16.71 |
| 2015 | 15.64 |
| 2014 | 16.71 |
37.34
484
11
20.977
